UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients

Ramachandran, P. ; Fraser, A. ; Agarwal, K. ; Austin, A. ; Brown, A. ; Foster, G. R. ; Fox, R. ; Hayes, P. C. ; Leen, C. ; Mills, P. R. ; Mutimer, D. J. ; Ryder, S. D. ; Dillon, J. F.

Alimentary pharmacology & therapeutics, 2012-03, Vol.35 (6), p.647-662 [Periódico revisado por pares]

Oxford: Blackwell Publishing Ltd

Texto completo disponível